| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
- |
| Employees |
- |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-2 |
| Cash Flow (TTM) (Millions $) |
0 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Daxor Corporation is a medical technology company based in New York, United States. The company specializes in the development and commercialization of innovative diagnostic blood volume measurement systems.
Their flagship product, the BVA-100, is an FDA-approved, state-of-the-art instrument that provides accurate and precise measurement of a patient's total blood volume. This technology aids in the diagnosis and treatment of various medical conditions related to blood volume abnormalities, such as heart failure, anemia, and hypovolemia.
Daxor's products and services cater to a wide range of medical professionals, including hospitals, research institutions, and healthcare providers. They aim to improve patient care by offering reliable, non-invasive blood volume measurement solutions that can potentially enhance treatment efficacy and reduce healthcare costs.
Additionally, Daxor Corporation conducts ongoing research and collaborates with healthcare experts to advance the field of blood volume diagnostics. Their innovations have the potential to revolutionize the way medical professionals diagnose and manage conditions related to blood volume, thereby positively impacting patient outcomes.
|
